Stryker to acquire Inari Medical for $80/share, boosting its vascular treatment portfolio with innovative technologies ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

The Ukrainian military said the footage showed soldiers in the country's 80th Separate Air Assault Brigade in a Stryker ...

Stryker announces agreement to acquire Inari Medical for $4.9 billion, resulting in a 21% jump in Inari's shares.

周一，Stryker Corporation (NYSE:SYK)股票仍然备受关注，Evercore ISI重申了其"优于大市"评级和400.00美元的目标价。该公司的分析强调了Stryker历来偏好以增长为导向的收购，这与他们对Inari Medical (NARI)高收入增长的预期相一致，尽管他们并未直接覆盖NARI或Penumbra (PEN)。 根据InvestingPro的数据，NARI ...

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news ...

Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be ...

Inari Medical's stock surged 6% amid reports of advanced acquisition talks with Stryker, potentially closing a deal this week ...

Stryker Corp. plans to pay $4.9 billion to acquire Inari Medical Inc., which makes devices to treat venous conditions.

这项收购是在Inari Medical聘请顾问探索多方潜在兴趣的报道之后进行的。Stifel分析师此前已将机械血栓切除（MT）市场确定为适合并购的领域，原因是其巨大的可寻址市场以及大型医疗技术公司在有机和非有机方式进入MT市场时面临的挑战。根据InvestingPro的数据，Inari在过去十二个月里展现了强劲的市场定位，收入增长令人印象深刻，达到22.4%。

In a report released yesterday, William Plovanic from Canaccord Genuity downgraded Inari Medical (NARI – Research Report) to a Hold, with a ...